JP2010532787A5 - - Google Patents

Download PDF

Info

Publication number
JP2010532787A5
JP2010532787A5 JP2010516038A JP2010516038A JP2010532787A5 JP 2010532787 A5 JP2010532787 A5 JP 2010532787A5 JP 2010516038 A JP2010516038 A JP 2010516038A JP 2010516038 A JP2010516038 A JP 2010516038A JP 2010532787 A5 JP2010532787 A5 JP 2010532787A5
Authority
JP
Japan
Prior art keywords
composition
mucositis
patient
item
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010516038A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010532787A (ja
JP5329538B2 (ja
Filing date
Publication date
Priority claimed from US12/215,700 external-priority patent/US9884899B2/en
Application filed filed Critical
Priority claimed from PCT/US2008/008340 external-priority patent/WO2009009034A2/en
Publication of JP2010532787A publication Critical patent/JP2010532787A/ja
Publication of JP2010532787A5 publication Critical patent/JP2010532787A5/ja
Application granted granted Critical
Publication of JP5329538B2 publication Critical patent/JP5329538B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010516038A 2007-07-06 2008-07-07 粘膜炎の治療において有用な方法および組成物 Expired - Fee Related JP5329538B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US95863407P 2007-07-06 2007-07-06
US60/958,634 2007-07-06
US96134307P 2007-07-20 2007-07-20
US60/961,343 2007-07-20
US12/215,700 2008-06-27
US12/215,700 US9884899B2 (en) 2007-07-06 2008-06-27 Methods for treating fibrosis using CRP antagonists
PCT/US2008/008340 WO2009009034A2 (en) 2007-07-06 2008-07-07 Methods and compositions useful in the treatment of mucositis

Publications (3)

Publication Number Publication Date
JP2010532787A JP2010532787A (ja) 2010-10-14
JP2010532787A5 true JP2010532787A5 (https=) 2012-08-16
JP5329538B2 JP5329538B2 (ja) 2013-10-30

Family

ID=40076757

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010516038A Expired - Fee Related JP5329538B2 (ja) 2007-07-06 2008-07-07 粘膜炎の治療において有用な方法および組成物

Country Status (9)

Country Link
EP (1) EP2185581B1 (https=)
JP (1) JP5329538B2 (https=)
CA (1) CA2692682C (https=)
DK (1) DK2185581T3 (https=)
ES (1) ES2554167T3 (https=)
HU (1) HUE026850T2 (https=)
PL (1) PL2185581T3 (https=)
PT (1) PT2185581E (https=)
WO (1) WO2009009034A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2409756T3 (es) 2006-12-04 2013-06-27 Promedior, Inc. Combinación de SAP y de enalapril para su uso en tratamiento de trastornos fibróticos o fibroproliferativos
US8497243B2 (en) 2007-07-06 2013-07-30 Promedior, Inc. Methods and compositions useful in the treatment of mucositis
US9884899B2 (en) 2007-07-06 2018-02-06 Promedior, Inc. Methods for treating fibrosis using CRP antagonists
CA2754961C (en) 2009-03-11 2018-04-10 Promedior, Inc. Treatment and diagnostic methods for hypersensitive disorders
EP2405929B1 (en) 2009-03-11 2018-06-06 Promedior Inc. A sap polypeptide for use in the treatment of autoimmune disorders and graft vs host disease
UA110323C2 (en) 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
EP2987803B1 (en) * 2009-06-17 2018-08-29 Promedior Inc. Sap variants and their use
RU2020111934A (ru) * 2013-10-08 2020-04-29 Промедиор, Инк. Способы лечения фиброзного рака
EP3669885A1 (en) * 2018-12-20 2020-06-24 Humanitas Mirasole S.p.A. Use of sap for the treatment of eurotiomycetes fungi infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2158292A (en) * 1991-05-31 1993-01-08 New England Deaconess Hospital Corporation Cea-binding proteins and methods for their isolation and use
GB9317120D0 (en) * 1993-08-17 1993-09-29 Royal Postgrad Med School Human serum amyloid p component
WO1999005394A1 (en) * 1997-07-23 1999-02-04 Cleansorb Limited Methods for deposition of materials in underground reservoirs
EP1879597A2 (en) * 2005-05-13 2008-01-23 Eisai Co., Ltd. Lipid a analogs for treating oral and gastrointestinal mucositis
EP1938104A2 (en) * 2005-10-17 2008-07-02 Institute for Systems Biology Tissue-and serum-derived glycoproteins and methods of their use
ES2409756T3 (es) * 2006-12-04 2013-06-27 Promedior, Inc. Combinación de SAP y de enalapril para su uso en tratamiento de trastornos fibróticos o fibroproliferativos

Similar Documents

Publication Publication Date Title
JP2010532787A5 (https=)
JP2024075713A5 (https=)
JP4660094B2 (ja) 新生物を治療するためのＥｒｂＢ３に基づく方法および組成物
US20100093636A1 (en) Methods of treating inflammation
US20110256130A1 (en) Methods of treating inflammatory disorders
JP2019196370A5 (https=)
JP2023538422A5 (https=)
JP2013533858A5 (https=)
RU2021130306A (ru) Композиции il-12, нацеленные на edb
JP2010503386A5 (https=)
JP2018510900A5 (https=)
JPWO2019107530A5 (https=)
JP5329538B2 (ja) 粘膜炎の治療において有用な方法および組成物
JP2019528306A5 (https=)
JP2018529661A5 (https=)
US20240342211A1 (en) Short-term activated dc1s and methods for their production and use
US10206976B2 (en) Protein particles comprising disulfide crosslinkers and uses related thereto
JP2013504603A5 (https=)
CN113599527B (zh) Apoe抑制剂与pd-1单抗联用在制备治疗消化道肿瘤的药物中的应用
JP2007521333A5 (https=)
Matsumoto-Miyai et al. Serotonergic regulation of distention-induced ATP release from the urothelium
Brzozowska et al. Polymorphism of regulatory region of GHRL gene (‐2531C> T) as a promising predictive factor for radiotherapy‐induced oral mucositis in patients with head neck cancer
WO2011116245A2 (en) Methods of treating inflammation
JP2025503251A5 (https=)
JP2023519580A5 (https=)